Tabirafusp tedromer

DRUG2 trials

Sponsors

Kodiak Sciences Inc

Conditions

Diabetic Macular Edema (DME)Wet Age-related Macular Degeneration

Phase 3

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Active, not recruitingNCT06556368

Kodiak Sciences IncWet Age-related Macular Degeneration

Start: 2024-08-23End: 2027-08-01Target: 675Updated: 2026-04-29

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

RecruitingNCT07734844

Kodiak Sciences IncDiabetic Macular Edema (DME)

Start: 2026-08-03End: 2029-09-01Target: 910Updated: 2026-08-21